Cargando…
Screening for Liver Fibrosis and Steatosis in a Large Cohort of Patients with Type 2 Diabetes Using Vibration Controlled Transient Elastography and Controlled Attenuation Parameter in a Single-Center Real-Life Experience
Background: Type 2 diabetes mellitus (T2DM), obesity, hyperlipidemia, and hypertension are considered risk factors for developing non-alcoholic fatty liver disease (NAFLD). This study aims to assess steatosis and fibrosis severity in a cohort of T2DM patients, using vibration controlled transient el...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230646/ https://www.ncbi.nlm.nih.gov/pubmed/32268517 http://dx.doi.org/10.3390/jcm9041032 |
_version_ | 1783535003390443520 |
---|---|
author | Sporea, Ioan Mare, Ruxandra Popescu, Alina Nistorescu, Silviu Baldea, Victor Sirli, Roxana Braha, Adina Sima, Alexandra Timar, Romulus Lupusoru, Raluca |
author_facet | Sporea, Ioan Mare, Ruxandra Popescu, Alina Nistorescu, Silviu Baldea, Victor Sirli, Roxana Braha, Adina Sima, Alexandra Timar, Romulus Lupusoru, Raluca |
author_sort | Sporea, Ioan |
collection | PubMed |
description | Background: Type 2 diabetes mellitus (T2DM), obesity, hyperlipidemia, and hypertension are considered risk factors for developing non-alcoholic fatty liver disease (NAFLD). This study aims to assess steatosis and fibrosis severity in a cohort of T2DM patients, using vibration controlled transient elastography (VCTE) and controlled attenuation parameter (CAP). Material and method: We performed a prospective study in which, in each patient, we aimed for 10 valid CAP and liver stiffness measurements (LSM). To discriminate between fibrosis stages, we used the following VCTE cut-offs: F ≥ 2–8.2 kPa, F ≥ 3–9.7 kPa, and F4 - 13.6 kPa. To discriminate between steatosis stages, we used the following CAP cut-offs: S1 (mild) – 274 dB/m, S2 (moderate) – 290dB/m, S3 (severe) – 302dB/m. Results: During the study period, we screened 776 patients; 60.3% had severe steatosis, while 19.4% had advanced fibrosis. Female gender, BMI, waist circumference, elevated levels of AST, total cholesterol, triglycerides, blood glucose, and high LSM were associated with severe steatosis (all p-value < 0.05). BMI, waist circumference, elevated levels of AST, HbA1c, and CAP were associated with advanced fibrosis (all p-values < 0.05). Conclusion: Higher BMI (obesity) comprises a higher risk of developing severe steatosis and fibrosis. Individualized screening strategies should be established for NAFLD according to different BMI. |
format | Online Article Text |
id | pubmed-7230646 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-72306462020-05-22 Screening for Liver Fibrosis and Steatosis in a Large Cohort of Patients with Type 2 Diabetes Using Vibration Controlled Transient Elastography and Controlled Attenuation Parameter in a Single-Center Real-Life Experience Sporea, Ioan Mare, Ruxandra Popescu, Alina Nistorescu, Silviu Baldea, Victor Sirli, Roxana Braha, Adina Sima, Alexandra Timar, Romulus Lupusoru, Raluca J Clin Med Article Background: Type 2 diabetes mellitus (T2DM), obesity, hyperlipidemia, and hypertension are considered risk factors for developing non-alcoholic fatty liver disease (NAFLD). This study aims to assess steatosis and fibrosis severity in a cohort of T2DM patients, using vibration controlled transient elastography (VCTE) and controlled attenuation parameter (CAP). Material and method: We performed a prospective study in which, in each patient, we aimed for 10 valid CAP and liver stiffness measurements (LSM). To discriminate between fibrosis stages, we used the following VCTE cut-offs: F ≥ 2–8.2 kPa, F ≥ 3–9.7 kPa, and F4 - 13.6 kPa. To discriminate between steatosis stages, we used the following CAP cut-offs: S1 (mild) – 274 dB/m, S2 (moderate) – 290dB/m, S3 (severe) – 302dB/m. Results: During the study period, we screened 776 patients; 60.3% had severe steatosis, while 19.4% had advanced fibrosis. Female gender, BMI, waist circumference, elevated levels of AST, total cholesterol, triglycerides, blood glucose, and high LSM were associated with severe steatosis (all p-value < 0.05). BMI, waist circumference, elevated levels of AST, HbA1c, and CAP were associated with advanced fibrosis (all p-values < 0.05). Conclusion: Higher BMI (obesity) comprises a higher risk of developing severe steatosis and fibrosis. Individualized screening strategies should be established for NAFLD according to different BMI. MDPI 2020-04-06 /pmc/articles/PMC7230646/ /pubmed/32268517 http://dx.doi.org/10.3390/jcm9041032 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Sporea, Ioan Mare, Ruxandra Popescu, Alina Nistorescu, Silviu Baldea, Victor Sirli, Roxana Braha, Adina Sima, Alexandra Timar, Romulus Lupusoru, Raluca Screening for Liver Fibrosis and Steatosis in a Large Cohort of Patients with Type 2 Diabetes Using Vibration Controlled Transient Elastography and Controlled Attenuation Parameter in a Single-Center Real-Life Experience |
title | Screening for Liver Fibrosis and Steatosis in a Large Cohort of Patients with Type 2 Diabetes Using Vibration Controlled Transient Elastography and Controlled Attenuation Parameter in a Single-Center Real-Life Experience |
title_full | Screening for Liver Fibrosis and Steatosis in a Large Cohort of Patients with Type 2 Diabetes Using Vibration Controlled Transient Elastography and Controlled Attenuation Parameter in a Single-Center Real-Life Experience |
title_fullStr | Screening for Liver Fibrosis and Steatosis in a Large Cohort of Patients with Type 2 Diabetes Using Vibration Controlled Transient Elastography and Controlled Attenuation Parameter in a Single-Center Real-Life Experience |
title_full_unstemmed | Screening for Liver Fibrosis and Steatosis in a Large Cohort of Patients with Type 2 Diabetes Using Vibration Controlled Transient Elastography and Controlled Attenuation Parameter in a Single-Center Real-Life Experience |
title_short | Screening for Liver Fibrosis and Steatosis in a Large Cohort of Patients with Type 2 Diabetes Using Vibration Controlled Transient Elastography and Controlled Attenuation Parameter in a Single-Center Real-Life Experience |
title_sort | screening for liver fibrosis and steatosis in a large cohort of patients with type 2 diabetes using vibration controlled transient elastography and controlled attenuation parameter in a single-center real-life experience |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230646/ https://www.ncbi.nlm.nih.gov/pubmed/32268517 http://dx.doi.org/10.3390/jcm9041032 |
work_keys_str_mv | AT sporeaioan screeningforliverfibrosisandsteatosisinalargecohortofpatientswithtype2diabetesusingvibrationcontrolledtransientelastographyandcontrolledattenuationparameterinasinglecenterreallifeexperience AT mareruxandra screeningforliverfibrosisandsteatosisinalargecohortofpatientswithtype2diabetesusingvibrationcontrolledtransientelastographyandcontrolledattenuationparameterinasinglecenterreallifeexperience AT popescualina screeningforliverfibrosisandsteatosisinalargecohortofpatientswithtype2diabetesusingvibrationcontrolledtransientelastographyandcontrolledattenuationparameterinasinglecenterreallifeexperience AT nistorescusilviu screeningforliverfibrosisandsteatosisinalargecohortofpatientswithtype2diabetesusingvibrationcontrolledtransientelastographyandcontrolledattenuationparameterinasinglecenterreallifeexperience AT baldeavictor screeningforliverfibrosisandsteatosisinalargecohortofpatientswithtype2diabetesusingvibrationcontrolledtransientelastographyandcontrolledattenuationparameterinasinglecenterreallifeexperience AT sirliroxana screeningforliverfibrosisandsteatosisinalargecohortofpatientswithtype2diabetesusingvibrationcontrolledtransientelastographyandcontrolledattenuationparameterinasinglecenterreallifeexperience AT brahaadina screeningforliverfibrosisandsteatosisinalargecohortofpatientswithtype2diabetesusingvibrationcontrolledtransientelastographyandcontrolledattenuationparameterinasinglecenterreallifeexperience AT simaalexandra screeningforliverfibrosisandsteatosisinalargecohortofpatientswithtype2diabetesusingvibrationcontrolledtransientelastographyandcontrolledattenuationparameterinasinglecenterreallifeexperience AT timarromulus screeningforliverfibrosisandsteatosisinalargecohortofpatientswithtype2diabetesusingvibrationcontrolledtransientelastographyandcontrolledattenuationparameterinasinglecenterreallifeexperience AT lupusoruraluca screeningforliverfibrosisandsteatosisinalargecohortofpatientswithtype2diabetesusingvibrationcontrolledtransientelastographyandcontrolledattenuationparameterinasinglecenterreallifeexperience |